Professional profile
About Shan
Healthcare Distribution, Marketing Services and Commercial Compliance in Chengdu
Shan He advises pharmaceutical and medical device companies on distribution channels, marketing services, CSO relationships and healthcare commercial compliance from Chengdu.
Mr. He practices at a Chengdu law firm. He was admitted in 2014 and has about twelve years of professional experience, working in English and Mandarin with Sichuan Bar Association credentials on file.
Healthcare distribution is a multi-tier system where margin compression creates pressure to build invoice stories. He maps distribution agreements, scores exclusivity survival, price-protection silence, return rights, stop-supply rights and inventory repurchase obligations against tender supply duties.
CSO and Marketing Fee Substance
CSO structures are not illegal by slogan; they become enforcement stories when money moves without provable promotion work product.
He applies the substance test: named deliverables such as call plans and materials approved by medical-legal, people who exist with payroll or service staff proportional to fees paid, fapiao and bank flow that match the contract narrative, and hospital-facing activity that does not collapse into individual HCP benefits.
Red flags include fees that track purchase volume more tightly than work hours, shell entities with the same ultimate beneficial owner as distributors or hospital-adjacent individuals, and WeChat-only performance reports with no artefacts.
Commercial Contracting and Disputes
When products are detained, delisted or disputed under supply contracts, he builds enforcement and settlement strategies with bilingual summaries for overseas manufacturers.
Hospital and group purchasing negotiations create contract and anti-bribery touchpoints. Training and third-party intermediary management are part of legal risk, not only commercial operations.
He reviews whether distributors actually escalate complaints or quietly discount them. UDI, traceability and warehouse practices affect recall readiness. Paper SOPs without system support are treated as residual risk that leadership should accept explicitly or fix.
How to Engage
Provide product type, distribution structure, marketing services agreements and any supply, payment or investigation issue already received. Scope is confirmed in writing through this profile's inquiry channel.
Capability
